Daptomycin biosynthesis in Streptomyces roseosporus:: cloning and analysis of the gene cluster and revision of peptide stereochemistry

被引:272
作者
Miao, V
Coëffet-LeGal, MF
Brian, P
Brost, R
Penn, J
Whiting, A
Martin, S
Ford, R
Parr, I
Bouchard, M
Silva, CJ
Wrigley, SK
Baltz, RH
机构
[1] Cubist Pharmaceut Inc, Lexington, MA 02421 USA
[2] Cubist Pharmaceut, Slough SL1 4EQ, Berks, England
来源
MICROBIOLOGY-SGM | 2005年 / 151卷
关键词
D O I
10.1099/mic.0.27757-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Daptomycin is a 13 amino acid, cyclic lipopeptide produced by a non-ribosomal peptide synthetase (NRPS) mechanism in Streptomyces roseosporus. A 128 kb region of S. roseosporus DNA was cloned and verified by heterologous expression in Streptomyces lividans to contain the daptomycin biosynthetic gene cluster (dpt). The cloned region was completely sequenced and three genes (dptA, dptBC, dptD) encoding the three subunits of an NRPS were identified. The catalytic domains in the subunits, predicted to couple five, six or two amino acids, respectively, included a novel activation domain and amino-acid-binding pocket for incorporating the unusual amino acid L-kynurenine (Kyn), three types of condensation domains and an extra epimerase domain (E-domain) in the second module. Novel genes (dptE, dptF) whose products likely work in conjunction with a unique condensation domain to acylate the first amino acid, as well as other genes (dptl, dptf) probably involved in supply of the non-proteinogenic amino acids L-3-methylglutamic acid and Kyn, were located next to the NRPS genes. The unexpected E-domain suggested that daptomycin would have D-Asn, rather than L-Asn, as originally assigned, and this was confirmed by comparing stereospecific synthetic peptides and the natural product both chemically and microbiologically.
引用
收藏
页码:1507 / 1523
页数:17
相关论文
共 65 条
[1]   Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations [J].
Akins, RL ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :454-459
[2]   DAPTOMYCIN DISRUPTS MEMBRANE-POTENTIAL IN GROWING STAPHYLOCOCCUS-AUREUS [J].
ALBORN, WE ;
ALLEN, NE ;
PRESTON, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) :2282-2287
[3]   INHIBITION OF MEMBRANE POTENTIAL-DEPENDENT AMINO-ACID-TRANSPORT BY DAPTOMYCIN [J].
ALLEN, NE ;
ALBORN, WE ;
HOBBS, JN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (12) :2639-2642
[4]   BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[5]  
Baltz R. H., 1997, BIOTECHNOLOGY ANTIBI, P415
[6]  
Baltz RH, 1997, DEV IND MICROBIOL, P93
[7]   In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers [J].
Barry, AL ;
Fuchs, PC ;
Brown, SD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1919-1922
[8]   Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2) [J].
Bentley, SD ;
Chater, KF ;
Cerdeño-Tárraga, AM ;
Challis, GL ;
Thomson, NR ;
James, KD ;
Harris, DE ;
Quail, MA ;
Kieser, H ;
Harper, D ;
Bateman, A ;
Brown, S ;
Chandra, G ;
Chen, CW ;
Collins, M ;
Cronin, A ;
Fraser, A ;
Goble, A ;
Hidalgo, J ;
Hornsby, T ;
Howarth, S ;
Huang, CH ;
Kieser, T ;
Larke, L ;
Murphy, L ;
Oliver, K ;
O'Neil, S ;
Rabbinowitsch, E ;
Rajandream, MA ;
Rutherford, K ;
Rutter, S ;
Seeger, K ;
Saunders, D ;
Sharp, S ;
Squares, R ;
Squares, S ;
Taylor, K ;
Warren, T ;
Wietzorrek, A ;
Woodward, J ;
Barrell, BG ;
Parkhill, J ;
Hopwood, DA .
NATURE, 2002, 417 (6885) :141-147
[9]  
Bernhardt A, 1997, J PEPT RES, V50, P143
[10]   DEACYLATION OF A21978C, AN ACIDIC LIPOPEPTIDE ANTIBIOTIC COMPLEX, BY ACTINOPLANES-UTAHENSIS [J].
BOECK, LD ;
FUKUDA, DS ;
ABBOTT, BJ ;
DEBONO, M .
JOURNAL OF ANTIBIOTICS, 1988, 41 (08) :1085-1092